ATA86690A - 2-substituierte n,n'-ditrimethoxybenzoylpiperazine, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen - Google Patents

2-substituierte n,n'-ditrimethoxybenzoylpiperazine, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen

Info

Publication number
ATA86690A
ATA86690A AT0086690A AT86690A ATA86690A AT A86690 A ATA86690 A AT A86690A AT 0086690 A AT0086690 A AT 0086690A AT 86690 A AT86690 A AT 86690A AT A86690 A ATA86690 A AT A86690A
Authority
AT
Austria
Prior art keywords
ditrimethoxybenzoylpiperazine
substituted
production
therapeutic compositions
therapeutic
Prior art date
Application number
AT0086690A
Other languages
English (en)
Other versions
AT399337B (de
Inventor
Pierre Braquet
Eduardo Pirotzky
Jean-Jacques Godfroid
Francoise Heymans
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of ATA86690A publication Critical patent/ATA86690A/de
Application granted granted Critical
Publication of AT399337B publication Critical patent/AT399337B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT0086690A 1989-04-15 1990-04-11 2-substituierte n,n'-ditrimethoxybenzoylpiperazine, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen AT399337B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898908587A GB8908587D0 (en) 1989-04-15 1989-04-15 New 2-substituted n,n'-ditrimethoxybenzoyl piperazines

Publications (2)

Publication Number Publication Date
ATA86690A true ATA86690A (de) 1994-09-15
AT399337B AT399337B (de) 1995-04-25

Family

ID=10655129

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0086690A AT399337B (de) 1989-04-15 1990-04-11 2-substituierte n,n'-ditrimethoxybenzoylpiperazine, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen

Country Status (32)

Country Link
US (1) US5019576A (de)
JP (1) JP2633709B2 (de)
KR (1) KR900016178A (de)
AR (1) AR247736A1 (de)
AT (1) AT399337B (de)
AU (1) AU631334B2 (de)
BE (1) BE1007245A3 (de)
CA (1) CA2014521C (de)
CH (1) CH681301A5 (de)
DE (1) DE4011925A1 (de)
DK (1) DK91890A (de)
DZ (1) DZ1407A1 (de)
ES (1) ES2019554A6 (de)
FI (1) FI92058C (de)
FR (2) FR2645743B1 (de)
GB (2) GB8908587D0 (de)
GR (1) GR1000355B (de)
HK (1) HK95092A (de)
IE (1) IE65058B1 (de)
IN (1) IN175799B (de)
IT (1) IT1241631B (de)
LU (1) LU87719A1 (de)
MA (1) MA21805A1 (de)
NL (1) NL9000798A (de)
NO (1) NO176098C (de)
NZ (1) NZ233250A (de)
OA (1) OA09446A (de)
PT (1) PT93736B (de)
SE (1) SE505186C2 (de)
SG (1) SG92092G (de)
TN (1) TNSN90051A1 (de)
ZA (1) ZA902566B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344830A (en) * 1992-12-10 1994-09-06 Merck & Co., Inc. N,N-diacylpiperazine tachykinin antagonists
US5883098A (en) * 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US5610165A (en) * 1994-02-17 1997-03-11 Merck & Co., Inc. N-acylpiperidine tachykinin antagonists
BR9608245A (pt) * 1995-05-02 1999-05-04 Schering Corp Derivados de piperazino como antagonistas de neurocinina
US5795894A (en) * 1995-05-02 1998-08-18 Schering Corporation Piperazino derivatives as neurokinn antagonists
BR9610277A (pt) * 1995-08-31 1999-07-06 Schering Corp Derivados de piperazino como antagonistas de neurowuinina
US5892039A (en) * 1995-08-31 1999-04-06 Schering Corporation Piperazino derivatives as neurokinin antagonists
US5869488A (en) * 1996-05-01 1999-02-09 Schering Corporation Piperazino derivatives as neurokinin antagonists
FR2780649B1 (fr) * 1998-07-06 2001-03-09 Univ Paris Vii Denis Diderot Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1243991A (en) * 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
FR2209560A1 (en) * 1972-12-07 1974-07-05 Degussa N-(Trialkoxyaroyl)-ethylenediamine derivs - useful as cardioactive medicaments, exhibit anti-ischaemic activity comparable to nitroglycerin
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
US4937246A (en) * 1987-11-25 1990-06-26 Takeda Chemical Industries, Ltd. PAF antagonist, 1,4-disubstituted piperazine compounds and production thereof
FI892468A7 (fi) * 1988-05-23 1989-11-24 Glaxo Group Ltd Piperazinderivat.
GB8823776D0 (en) * 1988-10-11 1988-11-16 Scras New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
GB8823775D0 (en) * 1988-10-11 1988-11-16 Scras New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use

Also Published As

Publication number Publication date
NO901631D0 (no) 1990-04-10
GR1000355B (el) 1992-06-25
AU5326190A (en) 1990-11-01
US5019576A (en) 1991-05-28
IE65058B1 (en) 1995-10-04
DK91890A (da) 1990-10-16
FR2645859B1 (fr) 1992-06-05
NO176098C (no) 1995-02-01
ES2019554A6 (es) 1991-06-16
SG92092G (en) 1992-12-04
OA09446A (fr) 1992-10-15
LU87719A1 (fr) 1990-07-24
SE9001269L (sv) 1990-10-16
PT93736B (pt) 1996-09-30
NL9000798A (nl) 1990-11-01
IT1241631B (it) 1994-01-25
FR2645743B1 (fr) 1992-06-05
KR900016178A (ko) 1990-11-12
AR247736A1 (es) 1995-03-31
IT9020020A1 (it) 1991-10-12
IN175799B (de) 1995-08-26
AT399337B (de) 1995-04-25
PT93736A (pt) 1990-11-20
FR2645859A1 (fr) 1990-10-19
NO901631L (no) 1990-10-16
IT9020020A0 (it) 1990-04-12
SE9001269D0 (sv) 1990-04-06
GB9007612D0 (en) 1990-05-30
SE505186C2 (sv) 1997-07-14
TNSN90051A1 (fr) 1991-03-05
DZ1407A1 (fr) 2004-09-13
CA2014521C (en) 1997-09-09
GB2230262A (en) 1990-10-17
JPH02292266A (ja) 1990-12-03
JP2633709B2 (ja) 1997-07-23
CA2014521A1 (en) 1990-10-15
FI901883A0 (fi) 1990-04-12
CH681301A5 (de) 1993-02-26
GB2230262B (en) 1992-02-26
FR2645743A1 (fr) 1990-10-19
BE1007245A3 (fr) 1995-05-02
IE901314L (en) 1990-10-15
GR900100270A (en) 1991-09-27
DK91890D0 (da) 1990-04-11
NZ233250A (en) 1991-03-26
FI92058C (fi) 1994-09-26
FI92058B (fi) 1994-06-15
ZA902566B (en) 1991-01-30
GB8908587D0 (en) 1989-06-01
HK95092A (en) 1992-12-04
NO176098B (no) 1994-10-24
DE4011925A1 (de) 1990-10-18
AU631334B2 (en) 1992-11-19
MA21805A1 (fr) 1990-12-31

Similar Documents

Publication Publication Date Title
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATA125988A (de) Pharmazeutische cefuroximaxetil-zusammensetzung und verfahren zu ihrer herstellung
DE3581328D1 (de) Derivate des menschlichen alpha-1-antitrypins und verfahren zu deren herstellung.
DE69017348D1 (de) Thyristor und Verfahren zu dessen Herstellung.
ATA56790A (de) Thieno-triazolo-diazepinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATA247489A (de) Festes pharmazeutisches piroxicam-präparat und verfahren zu seiner herstellung
DE3674582D1 (de) (s)-(-)-1-propyl-2',6'-pipecoloxylidid-hydrochloridmonohydrat, verfahren zu seiner herstellung und es enthaltendes pharmazeutisches praeparat.
ATE194616T1 (de) Substituierte 4-phenyl-thiazole derivate, verfahren zu deren herstellung und pharmazeutische zusammenstellungen die sie enthalten
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATA95690A (de) Thieno-triazolo-diazepinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE3872620D1 (de) (arylsulphonyl)-nitromethane, verfahren zu deren herstellung und deren verwendung in pharmazeutischen zusammensetzungen.
ATA260590A (de) Glyzerinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATA86690A (de) 2-substituierte n,n'-ditrimethoxybenzoylpiperazine, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATA328587A (de) Neue furanuronsaeure-derivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
DE3583780D1 (de) 2,3-dihydro-1h-inden-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATA146488A (de) 2-methoxymethylpenemverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE3873427D1 (de) Schmiermittelzusammensetzungen und verfahren zu deren herstellung.
ATA259590A (de) 3-(n-methyl-n-alkyl)-amino-2-methoxymethylenpro an-1-ol-derivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATA234689A (de) Neue 2-carbonyl substituierte n,n'-di(trimethoxybenzoyl)piperazine, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATA252892A (de) Benzofuranylimidazolderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE59009107D1 (de) 1-E3-(2-Hydroxy-3-alkylaminopropoxy)-2-thienyl]-3-phenyl-1-propanone und Verfahren zu deren Herstellung.
DE69002025D1 (de) Vinylidenfluoridcopolymer und verfahren zu seiner herstellung.
ATA53290A (de) Sdk peptide, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
AT399879B (de) Dihydro-pyrimido-thiazin-derivate und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee